Private hospital group Life Healthcare has delighted investors by declaring a special cash dividend of 235c per share. This move follows the finalised disposal of the group’s entire interest in its Life Molecular Imaging (LMI) business to Lantheus Radiopharmaceuticals UK. The JSE-listed group confirmed the landmark R13.9bn deal. They committed to returning the proceeds directly to shareholders. Management anticipated closing…
Tag: Healthcare Sector
-
Adcock Ingram’s Lenbucod Blocked by Court Ruling
The Pretoria High Court has dealt pharmaceutical giant Adcock Ingram a significant blow, ordering the company to cease selling and distributing its new painkiller, Lenbucod. This ruling effectively blocks Adcock Ingram’s Lenbucod from the market. The court found that the name infringed upon rival Aspen Pharmaceuticals’ existing trademark, Mybucod. This legal skirmish between the two JSE-listed heavyweights highlights the increasing…